Regulation of extracellular dopamine
by the norepinephrine transporter
by
Yamamoto BK, Novotney S
Department of Psychiatry,
Case Western Reserve University
School of Medicine,
Cleveland, Ohio, USA.
J Neurochem 1998 Jul; 71(1):274-80

ABSTRACT

There is growing evidence of an interaction between dopamine and norepinephrine. To test the hypothesis that norepinephrine terminals are involved in the uptake and removal of dopamine from the extracellular space, the norepinephrine uptake blocker desmethylimipramine (DMI) was infused locally while the extracellular concentrations of dopamine were simultaneously monitored. DMI increased the extracellular concentrations of dopamine in the medial prefrontal cortex and nucleus accumbens shell but had no effect in the striatum. The combined systemic administration of haloperidol and the local infusion of DMI produced an augmented increase in extracellular dopamine in the cortex compared with the increase produced by either drug alone. This synergistic increase in dopamine overflow is likely due to the combination of impulse-mediated dopamine release produced by haloperidol and blockade of the norepinephrine transporter. No such synergistic effects were observed in the nucleus accumbens and striatum. Local perfusion of the alpha2-antagonist idazoxan also increased the extracellular concentrations of dopamine in the cortex. Although the stimulation of extracellular dopamine by idazoxan and DMI could be due to the increased extracellular concentrations of norepinephrine produced by these drugs, an increase in dopamine also was observed in lesioned rats that were depleted of norepinephrine and challenged with haloperidol. This contrasted with the lack of an effect of haloperidol on cortical dopamine in unlesioned controls. These results suggest that norepinephrine terminals regulate extracellular dopamine concentrations in the medial prefrontal cortex and to a lesser extent in the nucleus accumbens shell through the uptake of dopamine by the norepinephrine transporter.

LHPA
Adrafinil
Modafinil
Reboxetine
Yohimbine
Mirtazapine
Desipramine
Alpha2 antagonism
Noradrenaline regulation
Noradrenaline and mood
Noradrenaline and ageing
Noradrenaline and allergy
Noradrenaline and anxiety
Noradrenaline and cognition
The noradrenaline transporter
Noradrenaline and depression
Noradrenergic-selective agents
Noradrenaline and dopamine co-release
Dopamine reuptake by noradrenaline neurons

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family